Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerJulie R. Brahmer, Jon M. Wigginton, Scott S. Tykodi et al.|New England Journal of Medicine|2012Cited by 8k
Mechanisms regulating PD-L1 expression on tumor and immune cellsShuming Chen, Suzanne L. Topalian|Journal for ImmunoTherapy of Cancer|2019Cited by 458
FAD-dependent enzyme-catalysed intermolecular [4+2] cycloaddition in natural product biosynthesisLei Gao, Xiaoguang Lei, Chengwei Liu et al.|Nature Chemistry|2020Cited by 160